Virtual Medicinal Product (VMP)
-
Alemtuzumab 30mg/1ml solution for infusion vials
Name Details
Current Name
Alemtuzumab 30mg/1ml solution for infusion vials
|
Start Date
13-01-2009
|
End Date
|
Previous Name
Alemtuzumab 30mg/1ml solution for injection vials
|
Start Date
19-04-2005
|
End Date
12-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L04AG06
BNF |
Current BNF
08020300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08020300
|
Start Date
14-08-2006
|
End Date
20-05-2013
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
9188011000001102 |
19-04-2005 |
|
VMP Ingredients
VMP ingredients table
Alemtuzumab |
Based on Ingredient Substance |
|
30 mg |
1 ml |
Name
Alemtuzumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Alemtuzumab
-
VMP
(Current) Alemtuzumab 30mg/1ml solution for in...
Virtual Medicinal Product Pack (VMPP) Information